Janus Henderson Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $478M | Buy |
|
|||||
|
2025
Q1 | $816M | Buy |
|
|||||
|
2024
Q4 | $866M | Sell |
|
|||||
|
2024
Q3 | $1.25B | Buy |
|
|||||
|
2024
Q2 | $670M | Buy |
|
|||||
|
2024
Q1 | $524M | Buy |
|
|||||
|
2023
Q4 | $438M | Sell |
|
|||||
|
2023
Q3 | $360M | Buy |
|
|||||
|
2023
Q2 | $353M | Sell |
|
|||||
|
2023
Q1 | $267M | Buy |
|
|||||
|
2022
Q4 | $286M | Sell |
|
|||||
|
2022
Q3 | $218M | Buy |
|
|||||
|
2022
Q2 | $91.9M | Sell |
|
|||||
|
2022
Q1 | $105M | Buy |
|
|||||
|
2021
Q4 | $101M | Buy |
|
|||||
|
2021
Q3 | $104M | Sell |
|
|||||
|
2021
Q2 | $92.7M | Sell |
|
|||||
|
2021
Q1 | $83.5M | Buy |
|
|||||
|
2020
Q4 | $108M | Buy |
|
|||||
|
2020
Q3 | $200M | Sell |
|
|||||
|
2020
Q2 | $140M | Buy |
|